ArticleOncotarget2017

The combination of temozolomide-irinotecan regresses a doxorubicin-resistant patient-derived orthotopic xenograft (PDOX) nude-mouse model of recurrent Ewing's sarcoma with a FUS-ERG fusion and

Kentaro Miyake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.